Who are Palvella Therapeutics, Inc.'s main suppliers?

Palvella Therapeutics, Inc. (PVLA) key suppliers include: CONTRACT-MANUFACTURING-ORGANIZATIONS, Ligand Pharmaceuticals Incorporated, ORANY, ORANY, Relay Therapeutics, Inc. and 1 more. View the full supplier network at chainsifter.com/chain/PVLA.

Who are Palvella Therapeutics, Inc.'s major customers?

Palvella Therapeutics, Inc. (PVLA) key customers include: ORANY, ORANY, Relay Therapeutics, Inc., Relay Therapeutics, Inc.. View the full customer network at chainsifter.com/chain/PVLA.

What sector is Palvella Therapeutics, Inc. in?

Palvella Therapeutics, Inc. (PVLA) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

PVLA Supply Chain: Palvella Therapeutics, Inc. Supplier List & 13 Relationships

6Suppliers

4Customers

3Debt Items

20Related Chains

Palvella Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
CONTRACT-MANUFACTURING-ORGANIZATIONS	CONTRACT-MANUFACTURING-ORGANIZATIONS	92%	The Company is dependent on contract manufacturing organizations ("CMOs") to supply products for research and development of its product candidates, including pre-clinical and clinical studies, and f…
LGND	Ligand Pharmaceuticals Incorporated	72%	Reciprocal relationship from LGND graph: ,115 23,401 22,262 Less accumulated depreciation and amortization ( 8,268 ) ( 6,655 ) $ 15,133 $ 15,607 Depreciation of equipment is computed using the straig…
ORANY	ORANY	72%	ting approval is obtained. We believe that this strategy allows us to maintain a more efficient infrastructure by eliminating the need for us to invest in our own manufacturing facilities, equipment …
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from PVLA graph: ting approval is obtained. We believe that this strategy allows us to maintain a more efficient infrastructure by el…
RLAY	Relay Therapeutics, Inc.	72%	Reciprocal relationship from RLAY graph: Reciprocal relationship from PVLA graph: Reciprocal relationship from RLAY graph: Reciprocal relationship from PVLA graph: Reciprocal relationship from RLAY g…
RLAY	Relay Therapeutics, Inc.	72%	ting approval is obtained. We believe that this strategy allows us to maintain a more efficient infrastructure by eliminating the need for us to invest in our own manufacturing facilities, equipment …

Palvella Therapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from PVLA graph: ion, future events, or otherwise, except as may be required by law. SUMMARY OF PRINCIPAL RISK FACTORS Below is a sum…
ORANY	ORANY	72%	ion, future events, or otherwise, except as may be required by law. SUMMARY OF PRINCIPAL RISK FACTORS Below is a summary of material factors that make an investment in our common stock speculative or…
RLAY	Relay Therapeutics, Inc.	72%	ion, future events, or otherwise, except as may be required by law. SUMMARY OF PRINCIPAL RISK FACTORS Below is a summary of material factors that make an investment in our common stock speculative or…
RLAY	Relay Therapeutics, Inc.	72%	Reciprocal relationship from RLAY graph: Reciprocal relationship from PVLA graph: ion, future events, or otherwise, except as may be required by law. SUMMARY OF PRINCIPAL RISK FACTORS Below is a summ…

Palvella Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
PVLA-DEBT	Debt stack $20.4M	90%	Market cache reports total debt of $20.4M.
PVLA-DEBT-11959	Warrants outstanding: 123238	90%	xbrl warrant detail from xbrl 2022-12-31.
PVLA-DEBT-11960	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2025-12-31.

Palvella Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Palvella Therapeutics, Inc..

Palvella Therapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
PVLA-OWNER-SUVRETTA-CAPITAL-MANAGEMENT-LLC	SUVRETTA CAPITAL MANAGEMENT, LLC	90%	13F overlay lists SUVRETTA CAPITAL MANAGEMENT, LLC as top holder; 185 tracked holders.

Palvella Therapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
ORANY	ORANGE	100.00	1	['customer', 'supplier']
LGND	Ligand Pharmaceuticals Incorporated	100.00	1	['supplier']
BLTE	Belite Bio, Inc	50.00	2
CYCN	Cyclerion Therapeutics, Inc.	50.00	2
CPRX	Catalyst Pharmaceuticals, Inc.	50.00	2
AYTU	Aytu BioPharma, Inc.	50.00	2
DARE	Daré Bioscience, Inc.	50.00	2
CNOB	ConnectOne Bancorp, Inc.	50.00	2
CANF	Can-Fite BioPharma Ltd.	50.00	2
DFTX	Definium Therapeutics, Inc.	50.00	2
CHUC	Charlie's Holdings, Inc.	50.00	2
CLNE	Clean Energy Fuels Corp.	50.00	2
DNTH	Dianthus Therapeutics, Inc.	50.00	2
FENC	Fennec Pharmaceuticals Inc.	50.00	2
EQR	Equity Residential	50.00	2
D	Dominion Energy, Inc.	50.00	2
DWTX	Dogwood Therapeutics, Inc.	50.00	2
ESS	Essex Property Trust, Inc.	50.00	2
ED	Consolidated Edison, Inc.	50.00	2
AMZE	Amaze Holdings, Inc.	50.00	2

Palvella Therapeutics, Inc. Supply Chain